[go: up one dir, main page]

GB201706250D0 - Combination therapy - Google Patents

Combination therapy

Info

Publication number
GB201706250D0
GB201706250D0 GBGB1706250.6A GB201706250A GB201706250D0 GB 201706250 D0 GB201706250 D0 GB 201706250D0 GB 201706250 A GB201706250 A GB 201706250A GB 201706250 D0 GB201706250 D0 GB 201706250D0
Authority
GB
United Kingdom
Prior art keywords
combination therapy
therapy
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1706250.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ADC Therapeutics SA
MedImmune Ltd
Original Assignee
ADC Therapeutics SA
MedImmune Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADC Therapeutics SA, MedImmune Ltd filed Critical ADC Therapeutics SA
Priority to GBGB1706250.6A priority Critical patent/GB201706250D0/en
Publication of GB201706250D0 publication Critical patent/GB201706250D0/en
Priority to CA3057744A priority patent/CA3057744A1/en
Priority to KR1020197032525A priority patent/KR20190137847A/en
Priority to BR112019021680-4A priority patent/BR112019021680A2/en
Priority to PCT/EP2018/060214 priority patent/WO2018193104A1/en
Priority to MX2019012465A priority patent/MX2019012465A/en
Priority to CN201880029617.2A priority patent/CN110582303A/en
Priority to EP18719542.5A priority patent/EP3612236A1/en
Priority to US16/605,708 priority patent/US11596696B2/en
Priority to AU2018253950A priority patent/AU2018253950A1/en
Priority to JP2019556813A priority patent/JP7402691B2/en
Ceased legal-status Critical Current

Links

GBGB1706250.6A 2017-04-20 2017-04-20 Combination therapy Ceased GB201706250D0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
GBGB1706250.6A GB201706250D0 (en) 2017-04-20 2017-04-20 Combination therapy
JP2019556813A JP7402691B2 (en) 2017-04-20 2018-04-20 Combination therapy with anti-CD25 antibody drug conjugate
PCT/EP2018/060214 WO2018193104A1 (en) 2017-04-20 2018-04-20 Combination therapy with an anti-cd25 antibody-drug conjugate
KR1020197032525A KR20190137847A (en) 2017-04-20 2018-04-20 Combination Therapy with Anti-CD25 Antibody-Drug Conjugates
BR112019021680-4A BR112019021680A2 (en) 2017-04-20 2018-04-20 COMBINATION THERAPY WITH ANTI-CD25 ANTIBODY-DRUG CONJUGATE ??
CA3057744A CA3057744A1 (en) 2017-04-20 2018-04-20 Combination therapy with an anti-cd25 antibody-drug conjugate
MX2019012465A MX2019012465A (en) 2017-04-20 2018-04-20 Combination therapy with an anti-cd25 antibody-drug conjugate.
CN201880029617.2A CN110582303A (en) 2017-04-20 2018-04-20 Combination therapy with anti-CD 25 antibody-drug conjugates
EP18719542.5A EP3612236A1 (en) 2017-04-20 2018-04-20 Combination therapy with an anti-cd25 antibody-drug conjugate
US16/605,708 US11596696B2 (en) 2017-04-20 2018-04-20 Combination therapy with an anti-CD25 antibody-drug conjugate
AU2018253950A AU2018253950A1 (en) 2017-04-20 2018-04-20 Combination therapy with an anti-CD25 antibody-drug conjugate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1706250.6A GB201706250D0 (en) 2017-04-20 2017-04-20 Combination therapy

Publications (1)

Publication Number Publication Date
GB201706250D0 true GB201706250D0 (en) 2017-06-07

Family

ID=58795870

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1706250.6A Ceased GB201706250D0 (en) 2017-04-20 2017-04-20 Combination therapy

Country Status (1)

Country Link
GB (1) GB201706250D0 (en)

Similar Documents

Publication Publication Date Title
PT3618875T (en) Combination therapy
IL272560A (en) Combination therapy
GB201713914D0 (en) Combination therapy
GB201713113D0 (en) Combination therapy
GB201706242D0 (en) Combination therapy
GB201706238D0 (en) Combination therapy
GB201706225D0 (en) Combination therapy
GB201706226D0 (en) Combination therapy
GB201706227D0 (en) Combination therapy
GB201706228D0 (en) Combination therapy
GB201706229D0 (en) Combination therapy
GB201706230D0 (en) Combination therapy
GB201706231D0 (en) Combination therapy
GB201706232D0 (en) Combination therapy
GB201706233D0 (en) Combination therapy
GB201706234D0 (en) Combination therapy
GB201706235D0 (en) Combination therapy
GB201706247D0 (en) Combination therapy
GB201706237D0 (en) Combination therapy
GB201706246D0 (en) Combination therapy
GB201706239D0 (en) Combination therapy
GB201706240D0 (en) Combination therapy
GB201706241D0 (en) Combination therapy
GB201706223D0 (en) Combination therapy
GB201706243D0 (en) Combination therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)